What's breaking now, across thousands of outlets.
Chantal Marx, head of investment research at FNB Wealth & Investments, shares her views on, amongst others, the local financial index and the JSE’s interim results.
We haven't written up this one. Moneyweb has the full story — the link below goes straight to it.
AstraZeneca’s deal talks with US-headquartered Bristol Myers Squibb, which Semafor confirms remain active, would strike another blow to the UK’s effort to keep hold of its corporate champions.
Mfundo Nkuhlu, COO of the Nedbank Group, reflects on financial sector transformation, the group's dividend allocation, and generating R8 billion in revenue despite challenging conditions.
California Gov. Gavin Newsom faces criticism from various sectors as his administration's aggressive regulatory policies regarding plastic packaging and agricultural standards prompt calls for…
Ships could sail a new “middle corridor” through the Strait of Hormuz under a deal to reopen the sea lane, Iran has claimed.
OPEC’s crude oil production recouped some more of its wartime losses last month with gains in Kuwait, Saudi Arabia and Iraq, though opaque shipping data complicated the process of tracking the group’s…
Nedbank today reported its results for the first six months of the year. Core earnings remained unchanged, and the directors have declared an interim dividend of R10.25 per share.
